A systematic analysis of anti-diabetic medicinal plants from cells to clinical trials
PeerJ · 05.01.2023 · 11 · e14639
DOI: 10.7717/peerj.14639 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift PeerJ, online erschienen am 05.01.2023. Verfasst von Simeon Omale und 4 weiteren Autor:innen. Beteiligte Einrichtung: African Centre for Excellence in Phytomedicine, University of Jos, Jos, Nigeria. Hauptthemen laut MEDLINE: Diabetes Mellitus, Plants, Medicinal. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 228 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: African Research Excellence Fund, Diabetes UK.
Abstract (Originalsprache)
Background
Diabetes is one of the fastest-growing health emergencies of the 21 st century, placing a severe economic burden on many countries. Current management approaches have improved diabetic care, but several limitations still exist, such as decreased efficacy, adverse effects, and the high cost of treatment, particularly for developing nations. There is, therefore, a need for more cost-effective therapies for diabetes management. The evidence-based application of phytochemicals from plants in the management of diseases is gaining traction. Methodology Various plants and plant parts have been investigated as antidiabetic agents. This review sought to collate and discuss published data on the cellular and molecular effects of medicinal plants and phytochemicals on insulin signaling pathways to better understand the current trend in using plant products in the management of diabetes. Furthermore, we explored available information on medicinal plants that consistently produced hypoglycemic effects from isolated cells to animal studies and clinical trials.
Results
There is substantial literature describing the effects of a range of plant extracts on insulin action and insulin signaling, revealing a depth in knowledge of molecular detail. Our exploration also reveals effective antidiabetic actions in animal studies, and clear translational potential evidenced by clinical trials.
Conclusion
We suggest that this area of research should be further exploited in the search for novel therapeutics for diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- African Centre for Excellence in Phytomedicine, University of Jos, Jos, Nigeria.
- Department of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, University of Jos, Jos, Nigeria.
- Department of Biochemistry, Faculty of Basic Medical Sciences, University of Jos, Jos, Nigeria.
- Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom.
ORCID-Profile: Kennedy I Amagon, Gwyn W Gould
Förderung
- African Research Excellence Fund
- Diabetes UK
Zitieren
APA
Omale, S., Amagon, K. I., Johnson, T. O., Bremner, S. K., & Gould, G. W. (2023). A systematic analysis of anti-diabetic medicinal plants from cells to clinical trials. PeerJ, 11, e14639. https://doi.org/10.7717/peerj.14639
Vancouver
Omale S, Amagon KI, Johnson TO, Bremner SK, Gould GW. A systematic analysis of anti-diabetic medicinal plants from cells to clinical trials. PeerJ. 2023;11:e14639. doi:10.7717/peerj.14639
BibTeX
@article{Omale2023,
author = {Omale, Simeon and Amagon, Kennedy I and Johnson, Titilayo O and Bremner, Shaun Kennedy and Gould, Gwyn W},
title = {A systematic analysis of anti-diabetic medicinal plants from cells to clinical trials},
journal = {PeerJ},
year = {2023},
volume = {11},
pages = {e14639},
doi = {10.7717/peerj.14639}
}
EUVIMED